Finding 1130962 (2024-001)

Significant Deficiency
Requirement
N
Questioned Costs
-
Year
2024
Accepted
2025-04-10
Audit: 353210
Auditor: Cbiz CPAS PC

AI Summary

  • Core Issue: The Foundation lacks adequate internal controls to ensure required disclaimers are included in conference materials as per grant agreement.
  • Impacted Requirements: Compliance with U.S. Department of Health and Human Services grant policies, specifically regarding disclaimers in publications.
  • Recommended Follow-Up: Enhance internal control procedures to ensure compliance with grant provisions for disclaimers in all relevant materials.

Finding Text

Finding No. 2024-001: Special Tests and Provisions – Significant Deficiency – Internal Control and Compliance Finding ALN 93.068 – Chronic Diseases: Research, Control, and Prevention, Grant Number 5NU58DP006907-04-00, Grant Period: September 30, 2020 to September 29, 2025 Criteria The terms and conditions of the Foundation’s grant agreement requires that the Foundation comply with the U.S. Department of Health and Human Services grant policies. Part II Terms and Conditions requires certain disclaimers be included in written conference materials or publications and by speakers and moderators. The Foundation should have internal control procedures in place to ensure compliance with the special provisions included in the grant agreement. Condition The Foundation did not have adequate internal control procedures in place to ensure that certain disclaimers required by the grant agreements are included in written conference materials or publications. Context One of two conference materials we reviewed did not include the required disclaimer. Cause The required disclaimer was not identified by the Program Director during the review process. Effect Management did not fully adhere to the requirements of the grant agreement. Questioned Costs None. Repeat Finding No. Recommendation We recommend that management enhance current internal control procedures to ensure that the Foundation is in compliance with the grant’s special provisions that requires certain disclaimers in written conference materials or publications. Views of Responsible Officials and Planned Corrective Actions See corrective action plan.

Categories

Special Tests & Provisions Significant Deficiency Internal Control / Segregation of Duties

Other Findings in this Audit

  • 554520 2024-001
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.068 Chronic Diseases: Research, Control, and Prevention $1.72M